The spirometer market size has grown strongly in recent years. It will grow from $1.27 billion in 2025 to $1.37 billion in 2026 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to rising prevalence of respiratory disorders, increasing hospital-based pulmonary diagnostics, growing awareness of lung health assessment, availability of standardized spirometry guidelines, expansion of diagnostic equipment usage.
The spirometer market size is expected to see strong growth in the next few years. It will grow to $1.83 billion in 2030 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to increasing adoption of home-based respiratory monitoring, rising demand for telehealth-enabled diagnostics, growing investments in digital healthcare infrastructure, increasing focus on early disease detection, expansion of software-integrated spirometry platforms. Major trends in the forecast period include increasing adoption of digital and connected spirometers, rising integration of software-based lung function analysis, growing use of portable and handheld spirometers, expansion of remote respiratory monitoring capabilities, enhanced focus on diagnostic accuracy and standardization.
The rising prevalence of chronic respiratory diseases is anticipated to drive demand for spirometers in the coming years. Chronic respiratory diseases are long-term conditions affecting the airways and other parts of the lungs, including asthma, chronic obstructive pulmonary disease (COPD), lung cancer, cystic fibrosis, sleep apnea, and occupational lung disorders. These conditions are largely associated with factors such as tobacco use, air pollution, occupational hazards, and genetic susceptibility. Spirometers play a vital role in the management of chronic respiratory diseases by assessing lung function, which enables clinicians to track disease progression and evaluate treatment outcomes. The resulting data supports timely adjustments to therapy and the development of personalized treatment strategies, ultimately improving respiratory health outcomes. For example, in November 2024, according to the Australian Institute of Health and Welfare, a government agency in Australia, respiratory conditions accounted for 7.2% of the total disease burden, 8.5% of non-fatal health loss, and 5.8% of premature mortality in 2023. As a result, the growing burden of chronic respiratory diseases is contributing to increased demand for spirometers.
Major companies in the spirometer market are concentrating on creating innovative solutions like app-based platforms to assist users in tracking lung health and sharing data with healthcare providers. These app-based platforms enable users to monitor their lung function, receive real-time feedback, and communicate with healthcare professionals for better management of respiratory conditions. For example, in May 2023, CMI Health Inc., a US-based medical equipment manufacturing firm, introduced AsthmaGo. AsthmaGo is an advanced app-based asthma management platform that integrates the SpiroLink digital spirometer, allowing users to conveniently monitor their lung performance and oxygen levels from home. This platform empowers asthma patients, including children, to manage their conditions effectively and share health data with caregivers for personalized care.
In January 2023, CAIRE Inc., a United States-based manufacturer of oxygen therapy and on-site oxygen generation systems, acquired MGC Diagnostics Holdings, Inc. for an undisclosed sum. This acquisition was intended to broaden CAIRE’s clinical healthcare offerings by incorporating advanced diagnostic technologies, thereby supporting more comprehensive patient care across the full spectrum of pulmonary disease progression. MGC Diagnostics Holdings, Inc. is a United States-based provider of cardiorespiratory diagnostic solutions, offering products such as spirometers, body plethysmographs, cardiopulmonary exercise testing systems, flow sensors, gas analyzers, and associated consumables.
Major companies operating in the spirometer market are Fukuda Sangyo Co. Ltd., Geratherm Respiratory GmbH, Jones Medical Instrument Company, Koninklijke Philips N.V., Ndd Medical Technologies Inc., nSpire Health Inc., Schiller AG, Sibelmed Sau, Smiths Medical Inc., Vitalograph Ltd., Vyaire Medical Inc., Welch Allyn Inc., Baxter International Inc., Benson Medical Instruments Co., Chest M.I. Inc., COSMED srl, Depisteo LLC, Henry Schein Inc., ICU Medical Inc., MGC Diagnostics Corporation, Midmark Corporation, Minato Medical Science Co Ltd., Nuvoair AB, OHD (SCHAUENBURG International, Recorders & Medicare Systems Pvt Ltd., Teleflex Incorporated, Morgan Scientific Inc., Futuremed America Inc.
North America was the largest region in the spirometer market share in 2025. The regions covered in the spirometer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the spirometer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the spirometer market by increasing costs of imported sensors, electronic components, precision flow meters, and embedded software systems used across handheld, tabletop, and desktop devices. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on imported medical electronics, while Asia-Pacific faces pricing pressure on export-oriented manufacturing. These tariffs are increasing procurement costs and slowing replacement cycles. However, they are also encouraging localized manufacturing, regional sourcing of components, and development of cost-optimized digital spirometry solutions.
The spirometer market research report is one of a series of new reports that provides spirometer market statistics, including spirometer industry global market size, regional shares, competitors with a spirometer market share, detailed spirometer market segments, market trends and opportunities, and any further data you may need to thrive in the spirometer industry. This spirometer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A spirometer is a device utilized to evaluate lung function by measuring the volume of air a person inhales and exhales, as well as the duration of exhalation. It serves as a diagnostic tool for conditions such as asthma, chronic obstructive pulmonary disease (COPD), and various other respiratory conditions affecting breathing.
Different types of spirometers include hand-held, tabletop, and desktop variants. Hand-held spirometers are particularly employed in longitudinal epidemiological studies to measure and monitor forced expiratory volume. The hand-held segment of the spirometer market facilitates at-home lung testing without necessitating a visit to a healthcare professional. The technology within a spirometer typically involves volume measurement, flow measurement, and peak flow measurement. Spirometer products encompass the device itself, consumables, accessories, and associated software. These devices find application in conditions such as asthma, COPD, cystic fibrosis, pulmonary fibrosis, and various other respiratory conditions. They are utilized across diverse settings including hospitals, clinics, and in home healthcare scenarios.
The spirometer market consists of sales of whole-body plethysmographs, pneumotachometers, fully electronic spirometers, peak flow meters, incentive spirometers, and windmill-type spirometers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The spirometer market size is expected to see strong growth in the next few years. It will grow to $1.83 billion in 2030 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to increasing adoption of home-based respiratory monitoring, rising demand for telehealth-enabled diagnostics, growing investments in digital healthcare infrastructure, increasing focus on early disease detection, expansion of software-integrated spirometry platforms. Major trends in the forecast period include increasing adoption of digital and connected spirometers, rising integration of software-based lung function analysis, growing use of portable and handheld spirometers, expansion of remote respiratory monitoring capabilities, enhanced focus on diagnostic accuracy and standardization.
The rising prevalence of chronic respiratory diseases is anticipated to drive demand for spirometers in the coming years. Chronic respiratory diseases are long-term conditions affecting the airways and other parts of the lungs, including asthma, chronic obstructive pulmonary disease (COPD), lung cancer, cystic fibrosis, sleep apnea, and occupational lung disorders. These conditions are largely associated with factors such as tobacco use, air pollution, occupational hazards, and genetic susceptibility. Spirometers play a vital role in the management of chronic respiratory diseases by assessing lung function, which enables clinicians to track disease progression and evaluate treatment outcomes. The resulting data supports timely adjustments to therapy and the development of personalized treatment strategies, ultimately improving respiratory health outcomes. For example, in November 2024, according to the Australian Institute of Health and Welfare, a government agency in Australia, respiratory conditions accounted for 7.2% of the total disease burden, 8.5% of non-fatal health loss, and 5.8% of premature mortality in 2023. As a result, the growing burden of chronic respiratory diseases is contributing to increased demand for spirometers.
Major companies in the spirometer market are concentrating on creating innovative solutions like app-based platforms to assist users in tracking lung health and sharing data with healthcare providers. These app-based platforms enable users to monitor their lung function, receive real-time feedback, and communicate with healthcare professionals for better management of respiratory conditions. For example, in May 2023, CMI Health Inc., a US-based medical equipment manufacturing firm, introduced AsthmaGo. AsthmaGo is an advanced app-based asthma management platform that integrates the SpiroLink digital spirometer, allowing users to conveniently monitor their lung performance and oxygen levels from home. This platform empowers asthma patients, including children, to manage their conditions effectively and share health data with caregivers for personalized care.
In January 2023, CAIRE Inc., a United States-based manufacturer of oxygen therapy and on-site oxygen generation systems, acquired MGC Diagnostics Holdings, Inc. for an undisclosed sum. This acquisition was intended to broaden CAIRE’s clinical healthcare offerings by incorporating advanced diagnostic technologies, thereby supporting more comprehensive patient care across the full spectrum of pulmonary disease progression. MGC Diagnostics Holdings, Inc. is a United States-based provider of cardiorespiratory diagnostic solutions, offering products such as spirometers, body plethysmographs, cardiopulmonary exercise testing systems, flow sensors, gas analyzers, and associated consumables.
Major companies operating in the spirometer market are Fukuda Sangyo Co. Ltd., Geratherm Respiratory GmbH, Jones Medical Instrument Company, Koninklijke Philips N.V., Ndd Medical Technologies Inc., nSpire Health Inc., Schiller AG, Sibelmed Sau, Smiths Medical Inc., Vitalograph Ltd., Vyaire Medical Inc., Welch Allyn Inc., Baxter International Inc., Benson Medical Instruments Co., Chest M.I. Inc., COSMED srl, Depisteo LLC, Henry Schein Inc., ICU Medical Inc., MGC Diagnostics Corporation, Midmark Corporation, Minato Medical Science Co Ltd., Nuvoair AB, OHD (SCHAUENBURG International, Recorders & Medicare Systems Pvt Ltd., Teleflex Incorporated, Morgan Scientific Inc., Futuremed America Inc.
North America was the largest region in the spirometer market share in 2025. The regions covered in the spirometer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the spirometer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the spirometer market by increasing costs of imported sensors, electronic components, precision flow meters, and embedded software systems used across handheld, tabletop, and desktop devices. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on imported medical electronics, while Asia-Pacific faces pricing pressure on export-oriented manufacturing. These tariffs are increasing procurement costs and slowing replacement cycles. However, they are also encouraging localized manufacturing, regional sourcing of components, and development of cost-optimized digital spirometry solutions.
The spirometer market research report is one of a series of new reports that provides spirometer market statistics, including spirometer industry global market size, regional shares, competitors with a spirometer market share, detailed spirometer market segments, market trends and opportunities, and any further data you may need to thrive in the spirometer industry. This spirometer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A spirometer is a device utilized to evaluate lung function by measuring the volume of air a person inhales and exhales, as well as the duration of exhalation. It serves as a diagnostic tool for conditions such as asthma, chronic obstructive pulmonary disease (COPD), and various other respiratory conditions affecting breathing.
Different types of spirometers include hand-held, tabletop, and desktop variants. Hand-held spirometers are particularly employed in longitudinal epidemiological studies to measure and monitor forced expiratory volume. The hand-held segment of the spirometer market facilitates at-home lung testing without necessitating a visit to a healthcare professional. The technology within a spirometer typically involves volume measurement, flow measurement, and peak flow measurement. Spirometer products encompass the device itself, consumables, accessories, and associated software. These devices find application in conditions such as asthma, COPD, cystic fibrosis, pulmonary fibrosis, and various other respiratory conditions. They are utilized across diverse settings including hospitals, clinics, and in home healthcare scenarios.
The spirometer market consists of sales of whole-body plethysmographs, pneumotachometers, fully electronic spirometers, peak flow meters, incentive spirometers, and windmill-type spirometers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Spirometer Market Characteristics
3. Spirometer Market Supply Chain Analysis
4. Global Spirometer Market Trends and Strategies
5. Spirometer Market Analysis of End Use Industries
7. Global Spirometer Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Spirometer Total Addressable Market (TAM) Analysis for the Market
9. Spirometer Market Segmentation
10. Spirometer Market Regional and Country Analysis
11. Asia-Pacific Spirometer Market
12. China Spirometer Market
13. India Spirometer Market
14. Japan Spirometer Market
15. Australia Spirometer Market
16. Indonesia Spirometer Market
17. South Korea Spirometer Market
18. Taiwan Spirometer Market
19. South East Asia Spirometer Market
20. Western Europe Spirometer Market
21. UK Spirometer Market
22. Germany Spirometer Market
23. France Spirometer Market
24. Italy Spirometer Market
25. Spain Spirometer Market
26. Eastern Europe Spirometer Market
27. Russia Spirometer Market
28. North America Spirometer Market
29. USA Spirometer Market
30. Canada Spirometer Market
31. South America Spirometer Market
32. Brazil Spirometer Market
33. Middle East Spirometer Market
34. Africa Spirometer Market
36. Spirometer Market Competitive Landscape and Company Profiles
37. Spirometer Market Other Major and Innovative Companies
40. Spirometer Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Spirometer Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses spirometer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for spirometer? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The spirometer market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Handheld; Table Top; Desktop2) By Technology: Volume Measurement; Flow Measurement
3) By Application: Asthma; COPD; Cystic Fibrosis; Pulmonary Fibrosis; Other Applications
4) By End-Use: Hospitals And Clinics; Home Healthcare
Subsegments:
1) By Hand-held: Digital Hand-held Spirometers; Mechanical Hand-held Spirometers2) By Table Top: Electronic Table Top Spirometers; Ultrasonic Table Top Spirometers
3) By Desktop: Digital Desktop Spirometers; Software-Integrated Desktop Spirometers
Companies Mentioned: Fukuda Sangyo Co. Ltd.; Geratherm Respiratory GmbH; Jones Medical Instrument Company; Koninklijke Philips N.V.; Ndd Medical Technologies Inc.; nSpire Health Inc.; Schiller AG; Sibelmed Sau; Smiths Medical Inc.; Vitalograph Ltd.; Vyaire Medical Inc.; Welch Allyn Inc.; Baxter International Inc.; Benson Medical Instruments Co.; Chest M.I. Inc.; COSMED srl; Depisteo LLC; Henry Schein Inc.; ICU Medical Inc.; MGC Diagnostics Corporation; Midmark Corporation; Minato Medical Science Co Ltd.; Nuvoair AB; OHD (SCHAUENBURG International; Recorders & Medicare Systems Pvt Ltd.; Teleflex Incorporated; Morgan Scientific Inc.; Futuremed America Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Spirometer market report include:- Fukuda Sangyo Co. Ltd.
- Geratherm Respiratory GmbH
- Jones Medical Instrument Company
- Koninklijke Philips N.V.
- Ndd Medical Technologies Inc.
- nSpire Health Inc.
- Schiller AG
- Sibelmed Sau
- Smiths Medical Inc.
- Vitalograph Ltd.
- Vyaire Medical Inc.
- Welch Allyn Inc.
- Baxter International Inc.
- Benson Medical Instruments Co.
- Chest M.I. Inc.
- COSMED srl
- Depisteo LLC
- Henry Schein Inc.
- ICU Medical Inc.
- MGC Diagnostics Corporation
- Midmark Corporation
- Minato Medical Science Co Ltd.
- Nuvoair AB
- OHD (SCHAUENBURG International
- Recorders & Medicare Systems Pvt Ltd.
- Teleflex Incorporated
- Morgan Scientific Inc.
- Futuremed America Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.37 Billion |
| Forecasted Market Value ( USD | $ 1.83 Billion |
| Compound Annual Growth Rate | 7.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 29 |
